Practice Location

294 STATE ROUTE 89A
COTTONWOOD, AZ 86326-3763

Phone: (928) 634-1331

What does STEVE HEILBRUNN research?

Dr. Heilbrunn studies how certain medical procedures and medications affect heart function, particularly in patients with conditions like mitral stenosis—a narrowing of the heart's mitral valve—and related issues like pulmonary hypertension, which is high blood pressure in the lungs. He explores the effects of percutaneous balloon valvuloplasty, a minimally invasive procedure that helps open narrowed heart valves, and the use of the drug flestolol, a quick-acting treatment for patients with severe heart problems. His goal is to improve heart health and prevent complications in patients undergoing heart treatments.

Key findings

  • In a study on percutaneous balloon valvuloplasty for mitral stenosis, patients saw a reduction in lung blood pressure from an average of 56 mm Hg to 48 mm Hg, enhancing their quality of life.
  • Research on the drug flestolol indicated that heart rate decreased in patients as the dose increased, showing its potential for quick intervention in critically ill patients.
  • Flestolol maintained the strength of heart contractions while making blood vessels more resistant, allowing for effective heart management without severe side effects.

Frequently asked questions

Does Dr. Heilbrunn study mitral stenosis?
Yes, Dr. Heilbrunn focuses on mitral stenosis and its related complications, especially pulmonary hypertension.
What treatments has Dr. Heilbrunn researched?
He has researched percutaneous balloon valvuloplasty and the drug flestolol for heart conditions.
Is Dr. Heilbrunn's work relevant to patients with pulmonary hypertension?
Absolutely, his studies on balloon valvuloplasty specifically target patients with pulmonary hypertension related to mitral stenosis.

Publications in plain English

Effect of percutaneous balloon valvuloplasty on pulmonary hypertension in mitral stenosis.

1993

American heart journal

Georgeson S, Panidis IP, Kleaveland JP, Heilbrunn S, Gonzales R

Plain English
This study looked at how a procedure called percutaneous balloon valvuloplasty (PMBV) affects blood pressure in the lungs of patients with a narrowed heart valve (mitral stenosis). The researchers found that after the procedure, the pressure in the heart decreased significantly, from an average of 56 mm Hg to 48 mm Hg, which is important because high pressure in the lungs can cause serious health problems. This is crucial for improving patients' quality of life and preventing further complications. Who this helps: Patients with mitral stenosis and pulmonary hypertension.

PubMed

Hemodynamic effects of flestolol, a titratable short-acting intravenous beta-adrenergic receptor blocker.

1988

Journal of clinical pharmacology

Strom J, Josephson M, Frishman WH, Singh B, Heilbrunn S +5 more

Plain English
This study looked at the effects of a drug called flestolol on heart function in 30 patients who were undergoing a common heart procedure. The researchers found that as they increased the dose of flestolol, the heart rate decreased and blood vessels became more resistant, but the overall strength of the heart's contractions only dropped a little. These results are important because they show that flestolol could be a useful treatment for patients in critical condition, as its effects are quick to start and wear off within half an hour. Who this helps: This helps critically ill patients needing careful heart management.

PubMed

Frequent Co-Authors

S Georgeson I P Panidis J P Kleaveland R Gonzales J Strom M Josephson W H Frishman B Singh S Osterle P Turlapaty

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.